The discovery of antiviral agents: Ten different compounds, ten different stories
- 25 April 2008
- journal article
- review article
- Published by Wiley in Medicinal Research Reviews
- Vol. 28 (6) , 929-953
- https://doi.org/10.1002/med.20128
Abstract
This review article, while autobiographical to some extent, describes the discovery of ten (classes of) antiviral compounds that have made (or just did not make) it to the market for the therapy of viral infections, but each in its own way influenced the landscape of our dealing with virus infections: (i) valaciclovir, (ii) BVDU, (iii) DHPA, (iv) cidofovir, (v) adefovir, (vi) tenofovir, (vii) stavudine, (viii) HEPT, (ix) TIBO, and (x) AMD3100. Successful drug development, as is certainly true for antiviral drugs and exemplified for the acyclic nucleoside phosphonates cidofovir, adefovir and tenofovir, requires patience and perseverance, and a close continuous and dedicated interaction between Chemistry, Biology/Medicine and Industry. © 2008 Wiley Periodicals, Inc. Med Res Rev, 28, No. 6, 929–953, 2008Keywords
This publication has 111 references indexed in Scilit:
- Cidofovir Resistance in Vaccinia Virus Is Linked to Diminished Virulencein MiceJournal of Virology, 2006
- Short-term antiviral activity of TMC278 – a novel NNRTI – in treatment-naive HIV-1-infected subjectsAIDS, 2006
- Acyclic nucleoside phosphonates: a key class of antiviral drugsNature Reviews Drug Discovery, 2005
- Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive PatientsA 3-Year Randomized TrialJAMA, 2004
- Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4The Journal of Experimental Medicine, 1997
- Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivativeBiochemical and Biophysical Research Communications, 1989
- Both 2′,3′-dideoxythymidine and its 2′,3′-unsaturated derivative (2′,3′-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitroBiochemical and Biophysical Research Communications, 1987
- Potent and selective anti-HTLV-IIILAV activity of 2′,3′-dideoxycytidinene, the 2′,3′-unsaturated derivative of 2′,3′-dideoxycytidineBiochemical and Biophysical Research Communications, 1986
- Oral (E)-5-(2-Bromovinyl)-2′-Deoxyuridine treatment of severe herpes zoster in cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1984
- Viral Infection and Host DefenseScience, 1974